Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Quipt Home Medical Corp has a consensus price target of $5.43 based on the ratings of 3 analysts. The high is $10 issued by Raymond James on February 16, 2024. The low is $2.3 issued by Canaccord Genuity on August 19, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Benchmark, and Canaccord Genuity on August 19, 2025, May 14, 2025, and May 13, 2025, respectively. With an average price target of $2.67 between Canaccord Genuity, Benchmark, and Canaccord Genuity, there's an implied -23.59% downside for Quipt Home Medical Corp from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Aug 19, 2025 | -34.1% | 1.72.3 | Previous Hold Current Hold | Get Alert | |
| May 14, 2025 | 14.61% | 46 | Previous Buy Current Buy | Get Alert | |
| May 13, 2025 | -51.29% | 1.74 | Previous Buy Current Hold | Get Alert | |
| Dec 20, 2024 | 71.92% | 67 | Previous Buy Current Buy | Get Alert | |
| Aug 21, 2024 | 100.57% | 79 | Previous Buy Current Buy | Get Alert | |
| Aug 16, 2024 | 71.92% | 68 | Previous Buy Current Buy | Get Alert | |
| May 20, 2024 | 157.88% | 910 | Previous Buy Current Buy | Get Alert | |
| May 17, 2024 | 129.23% | 89 | Previous Buy Current Buy | Get Alert | |
| Feb 16, 2024 | 186.53% | 1010 | Previous Outperform Current Market Perform | Get Alert | |
| Dec 20, 2023 | 186.53% | 1010 | Previous Buy Current Buy | Get Alert | |
| Jun 14, 2023 | 215.19% | 11 | Previous Current Buy | Get Alert | |
| May 17, 2023 | 186.53% | 10 | Previous Buy Current Buy | Get Alert | |
| Feb 15, 2023 | 186.53% | 10 | Previous Current Buy | Get Alert | |
| Feb 13, 2023 | 186.53% | 10 | Previous Current Buy | Get Alert |
The latest price target for Quipt Home Medical (NASDAQ:QIPT) was reported by Canaccord Genuity on August 19, 2025. The analyst firm set a price target for $2.30 expecting QIPT to fall to within 12 months (a possible -34.10% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Quipt Home Medical (NASDAQ:QIPT) was provided by Canaccord Genuity, and Quipt Home Medical maintained their hold rating.
There is no last upgrade for Quipt Home Medical
The last downgrade for Quipt Home Medical Corp happened on May 13, 2025 when Canaccord Genuity changed their price target from $4 to $1.7 for Quipt Home Medical Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quipt Home Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quipt Home Medical was filed on August 19, 2025 so you should expect the next rating to be made available sometime around August 19, 2026.
While ratings are subjective and will change, the latest Quipt Home Medical (QIPT) rating was a maintained with a price target of $1.70 to $2.30. The current price Quipt Home Medical (QIPT) is trading at is $3.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.